Edinburg, TX (February 16, 2021) – As the number of patients with COVID-19 continues to increase nationally, DHR Health Institute for Research and Development, which is affiliated with DHR Health, is pursuing innovative ways to treat patients infected with the potentially life-threatening disease. Through this study, first coordinated by the Mayo Clinic, DHR Health continues to provide convalescent-plasma therapy to patients in the Rio Grande Valley (RGV) hospitalized with severe COVID-19. “As an early initiative and recognizing the need, the DHR Health Institute for Research & Development established the RGV Collaborative for the Early Diagnosis, Prevention, and Treatment of COVID-19, which ...